Permanently Discontinued

MAR-TOPIRAMATE

MARCAN PHARMACEUTICALS INC

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is MAR-TOPIRAMATE discontinued in Canada?

Yes. The manufacturer has reported to Health Canada that MAR-TOPIRAMATE 25MG has been permanently discontinued (last updated July 5, 2018). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.

Why is MAR-TOPIRAMATE not available?

The reason the manufacturer reported: Delay in shipping of the drug.

Can I still get this?Possibly — same-ingredient product records found

StatusPermanently Discontinued

Same-ingredient products on file6 products

Affected strength25MG

Last updated2018-07-05

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Closest Matches

PMS-TOPIRAMATE

PHARMASCIENCE INC

25MG · DIN 02262991

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

JAMP-TOPIRAMATE

JAMP PHARMA CORPORATION

25MG · DIN 02435608

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

MINT-TOPIRAMATE

MINT PHARMACEUTICALS INC

25MG · DIN 02315645

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

Other Products

TOPAMAX

JANSSEN INC

50MG · DIN 02231385

Different strengthSame dosage formSame routeNo current shortage

Compare these two →

ACCEL-TOPIRAMATE

ACCEL PHARMA INC

200MG · DIN 02435357

Different strengthSame dosage formSame routeNo current shortage

Compare these two →

TOPIRAMATE TABLETS USP

ACCORD HEALTHCARE INC

200MG · DIN 02430819

Different strengthSame dosage formSame routeNo current shortage

Compare these two →

What this means

Does this mean I need to switch medications right away?

Not necessarily right away, but this product will not be returning to the market.

What should I do?

Talk to your pharmacist or prescriber about your options well before your current supply runs out.

DIN

02432099

Strength

25MG

Dosage Form

TABLET

Route

ORAL

Active Ingredient

TOPIRAMATE

See all TOPIRAMATE products →

Compare with another product →

Product Monograph

Official Product Monograph (Health Canada)

View official Health Canada drug record ↗

Shortage Timeline

Approximate — based on the dates HPSC reports were last updated, not confirmed onset or resolution dates. Gaps between bars are periods with no shortage on file.

Active/anticipated Resolved

Shortage History

2018-07-05

Active Shortage

Delay in shipping of the drug.

Other Products from MARCAN PHARMACEUTICALS INC

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

ACETAZOLAMIDE FOR INJECTION USP

500MG · DIN 02537893

AMIKACIN SULFATE INJECTION USP

500MG · DIN 02481073

ARSENIC TRIOXIDE FOR INJECTION

1MG · DIN 02554364

BICNU

100MG · DIN 02555093

BICNU

100MG · DIN 00297763

BORTEZOMIB FOR INJECTION

3.5MG · DIN 02493306